FDG PET/CT显示伴原始神经元成分的胶质母细胞瘤颅外转移
一例17岁女性WHO IV级伴原始神经元成分的胶质母细胞瘤(H3 G34突变型、IDH1野生型)患者,因初始MRI发现椎体转移而行全身FDG PET/CT分期。PET/CT显示颅外转移性疾病,包括脊髓软脑膜播散、骨转移及经脑室腹膜分流管的腹膜种植。该病例表明FDG PET/CT可用于揭示胶质母细胞瘤的远处转移。
要点
- 伴原始神经元成分的胶质母细胞瘤更易发生颅外转移。
- FDG PET/CT可显示胶质母细胞瘤的脊髓软脑膜播散、骨转移及腹膜种植。
- 儿童胶质母细胞瘤少见,伴原始神经元成分者尤其罕见。
核心结论
- FDG PET/CT可用于揭示伴原始神经元成分的胶质母细胞瘤的远处转移。
研究设计与样本
- 本文为个案报告,描述一例17岁女性患者的FDG PET/CT分期表现。
主要发现
- PET/CT显示颅外转移性疾病,包括脊髓软脑膜播散、骨转移及经脑室腹膜分流管的腹膜种植。
临床怎么用
- 对伴原始神经元成分的胶质母细胞瘤患者,可考虑FDG PET/CT以评估颅外转移。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 17-year-old girl with World Health Organization grade IV glioblastoma with primitive neuronal components (histone H3 G34-mutant and IDH1 wild type) underwent whole-body FDG PET/CT staging due to vertebral metastases on initial MRI. PET/CT revealed extracranial metastatic disease with spinal leptomeningeal dissemination, osseous metastases, and peritoneal seeding via a ventriculoperitoneal shunt. Glioblastoma is uncommon in pediatric patients and particularly those with primitive neuronal components. Extracranial metastases from glioblastoma are more common in those with primitive neuronal components. This case demonstrates the utility of FDG PET/CT for revealing distant metastases from glioblastoma.
引用
- Kay MD, Pariury HE, Perry A, et al. Extracranial Metastases From Glioblastoma With Primitive Neuronal Components on FDG PET/CT. Clin Nucl Med. 2020. PMID: 31876829. doi:10.1097/RLU.0000000000002896
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。